Amy Dyken controller at Fitzgerald Pharmaceutical Industries apublic company is currently preparing the calculation for basicand diluted earnings per share and the related disclosure forFitzgeralds financial statements. Below is selectedfinancial information for the fiscal year ended June 30 2012.